Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$463.1M
31M shares
52-week range
$8.27 – $30.10
33% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
www.clearpointneuro.comNo one on the platform currently holds CLPT.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 120,000 | $1.6M |
| Execution date | Ratio |
|---|---|
| 2015-07-27 | 1-for-35reverse |
No one on the platform has traded CLPT yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CLPT when is that offering I was told wouldn’t occur here
View on StockTwits ↗$CLPT Brutal for the shorts who thought they were going to make 40% in two days
View on StockTwits ↗$CLPT Mr Market is starting to understand the implications of AMT130 on '27 and '28 revenue, hence this not falling more after a terrible print... I'm buying anything under $12, but could see this pop on AMT130 BLA submission this quarter and then 6 months later after accelerated review/approval. If you don't think AMT130 is getting approved, you're mistaken. The Huntington's community got the FDA leadership fired after their flip flop last year.
View on StockTwits ↗$CLPT living the high life at the beach in expensive digs: https://www.youtube.com/watch?v=EECVaKWfYW4
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.